Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment

4 Jan 2023

Abstract excerpt

Bladder cancer (BCa) is associated with significant morbidity, with development linked to environmental, lifestyle, and genetic causes. Recurrence presents a significant issue and is managed in the clinical setting with intravesical chemotherapy or immunotherapy. In order to address challenges such as a limited supply of BCG and identifying cases likely to recur, it would be advantageous to use molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36674480
DOI: 10.3390/ijms24020964

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to TreatmentPMID 36674480Read ↗

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity Read ↗

The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence.Semantic proximity Read ↗

Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.Semantic proximity Read ↗

Correlation between the immune microenvironment and bladder cancer based on a prognostic miRNA risk modelSemantic proximity Read ↗

Biomarkers for bladder cancer aggressiveness.Semantic proximity Read ↗

Update on bladder cancer molecular subtypesSemantic proximity Read ↗

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.Semantic proximity Read ↗

A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urineSemantic proximity Read ↗

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysisSemantic proximity Read ↗

Prognostic Factors of Non-Muscle Invasive Bladder Cancer: A Study Based on Next-generation SequencingSemantic proximity Read ↗

Bladder Cancer: A Review.Semantic proximity Read ↗

Molecular targets and targeted therapies in bladder cancer managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.